Evidence map›Paper›PMID 40917268›Full record

ArticleClinical ophthalmology (Auckland, N.Z.)2025

Visual Outcomes and Prognostic Factors in Epiretinal Membrane Foveoschisis and Lamellar Macular Hole Surgery: A Retrospective Study.

Jan-Olof Carlsson, Anders Wirén, Maria Dukay, Koteiba Mageed, Sven Crafoord

Abstract read
In one paragraph

Article in Clinical ophthalmology (Auckland, N.Z.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Jan-Olof CarlssonFaculty of medicine and health Örebro University, Örebro, Sweden.
Anders WirénÖrebro University, Örebro, Sweden.
Maria DukayDepartment of Ophthalmology, Örebro University Hospital, Örebro, Sweden.
Koteiba MageedDepartment of Ophthalmology, Örebro University Hospital, Örebro, Sweden.
Sven CrafoordFaculty of medicine and health Örebro University, Örebro, Sweden.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: To assess vision outcomes, risk of complications and whether age, gender, specific OCT changes and preoperative vision affect the prognosis for postoperative vision development. We seek to clarify the prognosis of LMH after surgery and assess whether complications can be reduced with appropriate management. Methods: This retrospective study includes consecutive Lamellar Macular Hole (LMH) surgeries at Örebro University Hospital (2013-2019), re-evaluated using the OCT-based consensus definition. Cases were classified as Epiretinal Membrane Foveoschisis (ERM-F) or LMH. Pre- and postoperative data were collected from medical records. Statistical analyses were performed with support from medical statisticians. Results: Both the ERM-F and LMH groups showed Highly significant visual development (p-adj = 0.0010 and 0.0012 respectively), with a median visual improvement of 90% and 38%, respectively.Even the older LMH group, in which the majority (81%) exhibited pathological OCT findings, showed a median improvement of 61% and a significant visual improvement (adjusted p = 0.026). Conclusion: The results indicate good potential for visual improvement in both groups. Even if the LMH group experiences positive vision improvement, these patients would experience further improvement without the aforementioned OCT changes. Early surgery is highly recommended, ideally before photoreceptor damage occurs; if already present, it should be performed as soon as possible to prevent further OCT pathology.

Indexed as

ERM foveoschisislamellar macular holepreoperative factorvision improvement

Identifiers

PMID40917268
PMCPMC12413821

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.